Antibacterial Market Research Report by Crop (Cereals & Grains, Fruits & Vegetables, and Oilseeds & Pulses), by Type (Amide Antibacterial, Antibiotic Antibacterial, and Copper-Based Antibacterial), by Application, by State (California, Florida, and Illino

Antibacterial Market Research Report by Crop (Cereals & Grains, Fruits & Vegetables, and Oilseeds & Pulses), by Type (Amide Antibacterial, Antibiotic Antibacterial, and Copper-Based Antibacterial), by Application, by State (California, Florida, and Illinois) - United States Forecast to 2026 - Cumulative Impact of COVID-19

The United States Antibacterial Market size was estimated at USD 4,615.32 million in 2020 and expected to reach USD 5,272.60 million in 2021, at a CAGR 11.47% to reach USD 8,854.45 million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.


Market Segmentation & Coverage:

This research report categorizes the Antibacterial to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Crop, the market was studied across Cereals & Grains, Fruits & Vegetables, and Oilseeds & Pulses.

Based on Type, the market was studied across Amide Antibacterial, Antibiotic Antibacterial, Copper-Based Antibacterial, and Dithiocarbamate Antibacterial.

Based on Application, the market was studied across Foliar Spray and Soil Treatment.

Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Antibacterial Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Antibacterial Market, including Allecra Therapeutics GmbH, Allergan PLC, AstraZeneca PLC, Bayer AG, Boston Pharmaceuticals Inc., Bristol-Myers Squibb Company, Civica Rx, Cumberland Pharmaceuticals, Inc., Debiopharm Group, Eli Lilly and Company, Entasis Therapeutics Hldg, Forest Laboratories, Inc., GlaxoSmithKline plc, Iterum Therapeutics plc, Johnson & Johnson, Kyorin Pharmaceutical Co., Ltd., Locus Biosciences Inc., Melinta Therapeutics, Merck & Co., Inc., Micurx Pharmaceutical Inc., Mylan N.V., Nabriva Therapeutics plc, NacuGen Therapeutics Inc., Novartis AG, Pfizer Inc, R-Pharm Group, Sanofi S A, Shionogi Inc., Sichuan Pharmaceutical Co., Ltd., Spero Therapeutics, TenNor Therapeutics, Teva Pharmaceutical Industries Ltd., Theravance Biopharma, Inc., VenatoRx Pharmaceuticals, Inc., and Wockhardt Ltd..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Antibacterial Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Antibacterial Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Antibacterial Market?
4. What is the competitive strategic window for opportunities in the United States Antibacterial Market?
5. What are the technology trends and regulatory frameworks in the United States Antibacterial Market?
6. What is the market share of the leading vendors in the United States Antibacterial Market?
7. What modes and strategic moves are considered suitable for entering the United States Antibacterial Market?


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
3.1. Introduction
4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges
6. Antibacterial Market, by Crop
6.1. Introduction
6.2. Cereals & Grains
6.3. Fruits & Vegetables
6.4. Oilseeds & Pulses
7. Antibacterial Market, by Type
7.1. Introduction
7.2. Amide Antibacterial
7.3. Antibiotic Antibacterial
7.4. Copper-Based Antibacterial
7.5. Dithiocarbamate Antibacterial
8. Antibacterial Market, by Application
8.1. Introduction
8.2. Foliar Spray
8.3. Soil Treatment
9. California Antibacterial Market
10. Florida Antibacterial Market
11. Illinois Antibacterial Market
12. New York Antibacterial Market
13. Ohio Antibacterial Market
14. Pennsylvania Antibacterial Market
15. Texas Antibacterial Market
16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion
17. Company Usability Profiles
17.1. Allecra Therapeutics GmbH
17.2. Allergan PLC
17.3. AstraZeneca PLC
17.4. Bayer AG
17.5. Boston Pharmaceuticals Inc.
17.6. Bristol-Myers Squibb Company
17.7. Civica Rx
17.8. Cumberland Pharmaceuticals, Inc.
17.9. Debiopharm Group
17.10. Eli Lilly and Company
17.11. Entasis Therapeutics Hldg
17.12. Forest Laboratories, Inc.
17.13. GlaxoSmithKline plc
17.14. Iterum Therapeutics plc
17.15. Johnson & Johnson
17.16. Kyorin Pharmaceutical Co., Ltd.
17.17. Locus Biosciences Inc.
17.18. Melinta Therapeutics
17.19. Merck & Co., Inc.
17.20. Micurx Pharmaceutical Inc.
17.21. Mylan N.V.
17.22. Nabriva Therapeutics plc
17.23. NacuGen Therapeutics Inc.
17.24. Novartis AG
17.25. Pfizer Inc
17.26. R-Pharm Group
17.27. Sanofi S A
17.28. Shionogi Inc.
17.29. Sichuan Pharmaceutical Co., Ltd.
17.30. Spero Therapeutics
17.31. TenNor Therapeutics
17.32. Teva Pharmaceutical Industries Ltd.
17.33. Theravance Biopharma, Inc.
17.34. VenatoRx Pharmaceuticals, Inc.
17.35. Wockhardt Ltd.
18. Appendix
18.1. Discussion Guide
18.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES ANTIBACTERIAL MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. UNITED STATES ANTIBACTERIAL MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 3. UNITED STATES ANTIBACTERIAL MARKET: MARKET DYNAMICS
FIGURE 4. UNITED STATES ANTIBACTERIAL MARKET SIZE, BY CROP, 2020 VS 2026 (%)
FIGURE 5. UNITED STATES ANTIBACTERIAL MARKET SIZE, BY CROP, 2020 VS 2026 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES ANTIBACTERIAL MARKET SIZE, BY CROP, 2026
FIGURE 7. UNITED STATES ANTIBACTERIAL MARKET SIZE, BY CEREALS & GRAINS, 2018-2026 (USD MILLION)
FIGURE 8. UNITED STATES ANTIBACTERIAL MARKET SIZE, BY CEREALS & GRAINS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 9. UNITED STATES ANTIBACTERIAL MARKET SIZE, BY FRUITS & VEGETABLES, 2018-2026 (USD MILLION)
FIGURE 10. UNITED STATES ANTIBACTERIAL MARKET SIZE, BY FRUITS & VEGETABLES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 11. UNITED STATES ANTIBACTERIAL MARKET SIZE, BY OILSEEDS & PULSES, 2018-2026 (USD MILLION)
FIGURE 12. UNITED STATES ANTIBACTERIAL MARKET SIZE, BY OILSEEDS & PULSES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 13. UNITED STATES ANTIBACTERIAL MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
FIGURE 14. UNITED STATES ANTIBACTERIAL MARKET SIZE, BY TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES ANTIBACTERIAL MARKET SIZE, BY TYPE, 2026
FIGURE 16. UNITED STATES ANTIBACTERIAL MARKET SIZE, BY AMIDE ANTIBACTERIAL, 2018-2026 (USD MILLION)
FIGURE 17. UNITED STATES ANTIBACTERIAL MARKET SIZE, BY AMIDE ANTIBACTERIAL, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 18. UNITED STATES ANTIBACTERIAL MARKET SIZE, BY ANTIBIOTIC ANTIBACTERIAL, 2018-2026 (USD MILLION)
FIGURE 19. UNITED STATES ANTIBACTERIAL MARKET SIZE, BY ANTIBIOTIC ANTIBACTERIAL, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 20. UNITED STATES ANTIBACTERIAL MARKET SIZE, BY COPPER-BASED ANTIBACTERIAL, 2018-2026 (USD MILLION)
FIGURE 21. UNITED STATES ANTIBACTERIAL MARKET SIZE, BY COPPER-BASED ANTIBACTERIAL, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 22. UNITED STATES ANTIBACTERIAL MARKET SIZE, BY DITHIOCARBAMATE ANTIBACTERIAL, 2018-2026 (USD MILLION)
FIGURE 23. UNITED STATES ANTIBACTERIAL MARKET SIZE, BY DITHIOCARBAMATE ANTIBACTERIAL, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 24. UNITED STATES ANTIBACTERIAL MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 25. UNITED STATES ANTIBACTERIAL MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES ANTIBACTERIAL MARKET SIZE, BY APPLICATION, 2026
FIGURE 27. UNITED STATES ANTIBACTERIAL MARKET SIZE, BY FOLIAR SPRAY, 2018-2026 (USD MILLION)
FIGURE 28. UNITED STATES ANTIBACTERIAL MARKET SIZE, BY FOLIAR SPRAY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 29. UNITED STATES ANTIBACTERIAL MARKET SIZE, BY SOIL TREATMENT, 2018-2026 (USD MILLION)
FIGURE 30. UNITED STATES ANTIBACTERIAL MARKET SIZE, BY SOIL TREATMENT, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 31. UNITED STATES ANTIBACTERIAL MARKET: FPNV POSITIONING MATRIX
FIGURE 32. UNITED STATES ANTIBACTERIAL MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 33. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES ANTIBACTERIAL MARKET, BY TYPE
List of Tables
TABLE 1. UNITED STATES ANTIBACTERIAL MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. UNITED STATES ANTIBACTERIAL MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. UNITED STATES ANTIBACTERIAL MARKET SIZE, BY CROP, 2018-2026 (USD MILLION)
TABLE 5. UNITED STATES ANTIBACTERIAL MARKET SIZE, BY CEREALS & GRAINS, BY STATE, 2018-2026 (USD MILLION)
TABLE 6. UNITED STATES ANTIBACTERIAL MARKET SIZE, BY FRUITS & VEGETABLES, BY STATE, 2018-2026 (USD MILLION)
TABLE 7. UNITED STATES ANTIBACTERIAL MARKET SIZE, BY OILSEEDS & PULSES, BY STATE, 2018-2026 (USD MILLION)
TABLE 8. UNITED STATES ANTIBACTERIAL MARKET SIZE, BY TYPE, 2018-2026 (USD MILLION)
TABLE 9. UNITED STATES ANTIBACTERIAL MARKET SIZE, BY AMIDE ANTIBACTERIAL, BY STATE, 2018-2026 (USD MILLION)
TABLE 10. UNITED STATES ANTIBACTERIAL MARKET SIZE, BY ANTIBIOTIC ANTIBACTERIAL, BY STATE, 2018-2026 (USD MILLION)
TABLE 11. UNITED STATES ANTIBACTERIAL MARKET SIZE, BY COPPER-BASED ANTIBACTERIAL, BY STATE, 2018-2026 (USD MILLION)
TABLE 12. UNITED STATES ANTIBACTERIAL MARKET SIZE, BY DITHIOCARBAMATE ANTIBACTERIAL, BY STATE, 2018-2026 (USD MILLION)
TABLE 13. UNITED STATES ANTIBACTERIAL MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 14. UNITED STATES ANTIBACTERIAL MARKET SIZE, BY FOLIAR SPRAY, BY STATE, 2018-2026 (USD MILLION)
TABLE 15. UNITED STATES ANTIBACTERIAL MARKET SIZE, BY SOIL TREATMENT, BY STATE, 2018-2026 (USD MILLION)
TABLE 16. UNITED STATES ANTIBACTERIAL MARKET: SCORES
TABLE 17. UNITED STATES ANTIBACTERIAL MARKET: BUSINESS STRATEGY
TABLE 18. UNITED STATES ANTIBACTERIAL MARKET: PRODUCT SATISFACTION
TABLE 19. UNITED STATES ANTIBACTERIAL MARKET: RANKING
TABLE 20. UNITED STATES ANTIBACTERIAL MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 21. UNITED STATES ANTIBACTERIAL MARKET: MERGER & ACQUISITION
TABLE 22. UNITED STATES ANTIBACTERIAL MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 23. UNITED STATES ANTIBACTERIAL MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 24. UNITED STATES ANTIBACTERIAL MARKET: INVESTMENT & FUNDING
TABLE 25. UNITED STATES ANTIBACTERIAL MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 26. UNITED STATES ANTIBACTERIAL MARKET: LICENSE & PRICING

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook